Risks Associated With Benzodiazepine Long-Term Use in Chronic Insomnia: A Systematic Review and (Network) Meta-Analysis.

J Sleep ResJun 11, 2026 (epub)

Dieter Riemann, Chiara Baglioni, Christoph Nissen et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the risks of long-term benzodiazepine use in adults with chronic insomnia, analyzing 27 studies. It found that individuals using benzodiazepines experienced significantly higher levels of depression and anxiety compared to healthy sleepers, while their insomnia severity was less than those not on medication. The study underscores the need for cautious prescribing practices.

Key findings

  • Benzodiazepine users had more severe insomnia than healthy sleepers but less severe than non-users.
  • Users experienced significantly higher levels of depression and anxiety compared to healthy sleepers.
  • The risk of falls was similar between benzodiazepine users and non-users.

Why it matters

Understanding the risks associated with long-term benzodiazepine use is crucial for clinicians managing chronic insomnia, as it may inform treatment decisions and encourage the exploration of safer alternatives.

Source

Published in J Sleep Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.